Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain

References

• World Health Organization Geneva2014 Available from: http://www.who.int/tobacco/health_priority/en/index.htmlAccessed July 21, 2014
   Google Scholar
• BanegasJRDíez-GañánLBañuelos-MarcoBSmoking-attributable deaths in Spain, 2006Med Clin (Barc)20111369710220980030
   PubMed Web of Science ®Google Scholar
• FioreMCJaénCRBakerTBTreating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline2013Rockville, MDU.S. Department of Health and Human Services. Public Health Service Available from: http://www.ncbi.nlm.nih.gov/books/NBK63952/Accessed September 27, 2013
   Google Scholar
• RennardSIDaughtonDMSmoking cessationClin Chest Med20143516517624507844
   PubMed Web of Science ®Google Scholar
• RigottiNASmoking cessation in patients with respiratory disease: existing treatments and future directionsLancet Respir Med2013124125024429130
   PubMed Web of Science ®Google Scholar
• LockKWilsonKMurphyDRiescoJAA cost-effectiveness model of smoking cessation based on a randomized controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary diseaseExpert Opin Pharmacother2011122613262622017336
   PubMed Web of Science ®Google Scholar
• Jiménez-RuizCARiesco MirandaJAAltet GómezNSociedad Española de Neumología y Cirugía Torácica (SEPAR)Treatment of smoking in smokers with chronic obstructive pulmonary disease. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)Arch Bronconeumol20134935436323642760
   PubMed Web of Science ®Google Scholar
• SEMERGENConsenso para la prevención y terapia de la enfermedad tabáquica [Consensus for prevention and therapy of smoking];2007 Available from: http://www.semergen.esAccessed June 26, 2014
   Google Scholar
• González-EnríquezJSalvador-LlivinaTLópez-NicolásAThe effects of implementing a smoking cessation intervention in Spain on morbidity, mortality and health care costsGac Sanit20021630831712106550
   PubMedGoogle Scholar
• Sicras-MainarARejas-GutiérrezJNavarro-ArtiedaRIbañez-NollaJThe effect of quitting smoking on costs and healthcare utilization in patients with chronic obstructive pulmonary disease: a comparison of current smokers versus ex-smokers in routine clinical practiceLung201419250551824816902
   PubMed Web of Science ®Google Scholar
• Jiménez-RuizCARiesco MirandaJARamos PinedoARecommendations for pharmacological tobacco cessation treatments: proposals for financingArch Bronconeumol20084421321918423183
   PubMed Web of Science ®Google Scholar
• López-BastidaJOlivaJAntoñanzasFSpanish recommendations on economic evaluation of health technologiesEur J Health Econ20101151352020405159
   PubMed Web of Science ®Google Scholar
• SullivanSDMauskopfJAAugustovskiFBudget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task ForceValue Health20141751424438712
   PubMed Web of Science ®Google Scholar
• Sicras-MainarANavarro ArtiedaRDíaz CerezoSMartí-SanchézBSanz De BurgoaVAbstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary careAten Primaria20114348248921382649
   PubMed Web of Science ®Google Scholar
• SorianoJBAncocheaJMiravitllesMRecent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007Eur Respir J20103675876519996189
   PubMed Web of Science ®Google Scholar
• National Institute of Statistics (INE) of SpainProyecciones de la población española for 2013 [Spanish population projections for 2013]2013 Available from: http://www.ine.esAccessed September 27, 2013
   Google Scholar
• de Miguel DiezJCarrasco GarridoPGarcía CarballoMDeterminants and predictors of the cost of COPD in primary care: a Spanish perspectiveInt J Chron Obstruct Pulmon Dis2008370171219281084
   PubMedGoogle Scholar
• Comité Nacional para la Prevención del Tabaquismo2008National Committee for Prevention of smoking: 2008 Available from: http://www.cnpt.es/listado-recursos.asp?id_categoria=23&id_subcategoria=-1&pagina=8Accessed September 27, 2013
   Google Scholar
• Jiménez RuizCAFernando MasaJSobradilloVPrevalence of and attitudes towards smoking in a population over 40 years of ageArch Bronconeumol20003624124410916663
   PubMedGoogle Scholar
• de Lucas RamosPÁlvaro AlvarezDActualizaciones en la EPOC 2010 [Update for COPD 2010]Monografías NEUMOMADRIDXV2010 Available from: http://www.neumomadrid.org/descargas/monog_neumomadrid_xv.pdfAccessed September 27, 2013
   Google Scholar
• GetsiosDMartonJPRevankarNSmoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventionsPharmacoeconomics20133176778023821436
   PubMed Web of Science ®Google Scholar
• KrallEAGarveyAJGarciaRISmoking relapses after 2 years of abstinence: findings from the VA Normative Aging StudyNicotine Tob Res200249510011906685
   PubMedGoogle Scholar
• TashkinDKannerRBaileyWSmoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomized trialLancet20013571571157511377644
   PubMed Web of Science ®Google Scholar
• TashkinDPRennardSHaysJTMaWLawrenceDLeeTCEffects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trialChest201113959159920864613
   PubMed Web of Science ®Google Scholar
• TønnesenPMikkelsenKBremannLNurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral supportChest200613033434216899830
   PubMed Web of Science ®Google Scholar
• ZhuSHAndersonCMTedeschiGJEvidence of real-world effectiveness of a telephone quit line for smokersN Engl J Med20023471087109312362011
   PubMed Web of Science ®Google Scholar
• Drug Catalogue of the Consejo General de Colegios de Farmacéuticos. Bot Plus Web2013Drug Catalogue of the General Council of Official Colleges of Pharmacists Available from: http://www.portalfarma.comAccessed September 27, 2013
   Google Scholar
• Royal Decree-Law (RD)Real Decreto-ley 8/2010, de 20 de mayo, por el que se adoptan medidas extraordinarias para la reducción del déficit públicoBOE [Spain’s Official Government Gazette] de 24 de Mayo20101262010 Available from: www.boe.es/boe/dias/2010/05/24/pdfs/BOE-A-2010-8228.pdfAccessed June 25, 2014
   Google Scholar
• WetterDWCofta-GunnLFouladiRTCinciripiniPMSuiDGritzERLate relapse/sustained abstinence among former smokers: a longitudinal studyPrev Med2004391156116315539050
   PubMed Web of Science ®Google Scholar
• Jiménez RuizCARamos PinedoACicero GuerreroAMayayo UlibarriMCristobal FernándezMLopez GonzalezGCharacteristics of COPD smokers and effectiveness and safety of smoking cessation medicationsNicotine Tob Res2012141035103922345320
   PubMed Web of Science ®Google Scholar
• BrosaMGisbertRRodríguezJMSotoJPrincipios, métodos y aplicaciones del análisis del impacto presupuestario en el sector sanitario [Principles, methods and applications for budgetary impact analysis for health interventions]Pharmacoecon Span Res Artic200526478
   Google Scholar
• CornuzJGilbertAPingetCCost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparisonTob Control20061515215916728744
   PubMed Web of Science ®Google Scholar
• SongFRafteryJAveyardPHydeCBartonPWoolacottNCost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysisMed Decis Making2002225 supplS26S3712369228
   PubMed Web of Science ®Google Scholar
• Fernández de Bobadilla OsorioJSánchez-MaestreCBrosaRiestraMArroyoOSanz De BurgoaVWilsonKCost effectiveness analysis of varenicline (Champix) for the treatment of smoking in SpainAn Med Interna20082534234819295994
   PubMedGoogle Scholar
• AntoñanzasFPortilloFEvaluación económica del empleo de terapias farmacológicas para la cesación en el hábito tabáquico [Economic evaluation of pharmacotherapies for smoking cessation]Gac Sanit20031739340314599422
   PubMedGoogle Scholar
• de GrandaJICarriónFAlonsoSArea de Tabaquismo de la SEPARTobacco addiction: care and servicesArch Bronconeumol20064260060417125696
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis, Management and Prevention of COPDGlobal Initiative for Chronic Obstructive Lung Disease2010 Available from: http://www.goldcopd.org/Accessed September 2013
   Google Scholar
• MenzinJLinesLMMartonJEstimating the short-term clinical and economic benefits of smoking cessation: do we have it right?Expert Rev Pharmacoecon Outcomes Res2009925726419527098
   PubMedGoogle Scholar
• WarnerKEMendezDSmithDGThe financial implications of coverage of smoking cessation treatment by managed care organizationsInquiry200441576915224960
   PubMed Web of Science ®Google Scholar
• Tarifas de asistencia sanitaria ambulatoria de la Comunidad de Madrid (B.O.C.M. 215 de 10 de septiembre de 2013)Tariffs of healthy outpatient resources of Autonomous Community of Madrid2013 Available from: http://w3.bocm.es/boletin/CM_Orden_BOCM/2013/09/10/BOCM-20130910-1.PDFAccessed September 27, 2013
   Google Scholar
• Guía de deshabituación tabáquica del Instituto Catalán de la Salud2013Guideline for smoking cessation of the Catalonia Institute of Health Available from: http://www.ics.gencat.cat/3clics/main.php?page=GuiaPage&idGuia=1&lang=CASAccessed September 27, 2013
   Google Scholar